Status Report on the Management of Dermatofibrosarcoma Protuberans: Is There a Viable Role for the Use of Imatinib Mesylate? In Which Cases May It Be Therapeutically Helpful and in Which Cases Not? March 17, 2011 Grace K. Kim, DO; James Q. Del Rosso, DO, FAOCD Dr. Kim CONTINUE READING »
